| Today's Top Story |  |  | | - Supreme Court to hold human-gene patent hearing today
The Supreme Court is set to hear oral arguments today in a case that could determine whether companies have the right to patent human genes. The specific dispute involves Myriad Genetics' patents on two genes linked to breast and ovarian cancer. Critics of gene patents said that patents should not be allowed on parts of the human body and that patents impede medical progress. Myriad Genetics and its supporters, including BIO, meanwhile, said that a ruling against gene patents could force companies to stop investing in genetics research, to the detriment of patients and also the economy. The New York Times (tiered subscription model) (4/14), Reuters (4/14), The Hill/Healthwatch blog (4/14)       | Health Care & Policy | | | | - Report: 5,500 cancer drugs in the pipeline
Almost 5,500 out of 17,000 investigational drugs are being developed for the treatment of cancer, and the strong majority of them would be first-in-class treatments, according to a report from PhRMA. "Biopharmaceutical companies, working with other partners in the American research ecosystem, have made incredible progress in helping confront some of the most challenging and costly diseases facing patients around the world," PhRMA president and CEO John J. Castellani said. OncLive (4/11) - Veredus Labs assay identifies H7N9 bird flu
Veredus Laboratories has reported that the current version of its VereFlu test can diagnose H7N9 influenza. The lab-on-a-chip assay differentiates influenza A and B viruses, including H5N1 and H1N1. RTT News (4/10) | Company & Financial News | | | | | Food & Agriculture | | | | | Hot Topics | | | | Top five news stories selected by BIO SmartBrief readers in the past week. - Results based on number of times each story was clicked by readers.
| Industrial & Environmental | | | | - AEC's Coleman: Anti-ethanol bill would hurt advanced biofuels
President Barack Obama's 2014 budget proposal does not contain details on how the government intends to raise money for research and development of advanced biofuels and alternative fuel vehicles. Rep. Bob Goodlatte, R-Va., is proposing capping the percentage of ethanol in the U.S. fuel mix and repealing the federal standard for ethanol. Advanced Ethanol Council Executive Director Brooke Coleman says that although Goodlatte speaks out against corn-based ethanol, his proposal would stifle the development of advanced biofuels. MotherJones.com/Climate Desk (4/11) | News from BIO | | | | - Evidence, Coverage and Incentives: A PMC/BIO Solutions Summit
BIO and the Personalized Medicine Coalition have partnered to bring together all stakeholders to discuss potential solutions to advance personalized medicine on Wednesday in Washington, D.C. A key focus of the summit is a determination of the nature and level of evidence necessary to make reliable and appropriate decisions on the coverage, regulation and adoption of personalized medicine products. Other topics to be addressed are market access issues for companion diagnostics and incentives for the development of personalized medicine products. Learn more and register.
| SmartQuote | | | |  | It has ever been my experience that folks who have no vices have very few virtues."
--Abraham Lincoln,
16th U.S. president  |
| | This SmartBrief was created for jmabs1@gmail.com
| | | Read more at SmartBrief.com | | A powerful website for SmartBrief readers including: | | | | | | | | | | Recent BIO SmartBrief Issues: - Friday, April 12, 2013
- Thursday, April 11, 2013
- Wednesday, April 10, 2013
- Tuesday, April 09, 2013
- Monday, April 08, 2013
| | | Lead Editor: Tom Parks
Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004 | | | | | | © 1999-2013 SmartBrief, Inc.® Legal Information |
|
No comments:
Post a Comment